Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma

Inhibition of aldose reductase prevents angiogenesis in vitro and in vivo

(2011) Ravinder Tammali et al.   ANGIOGENESIS

Tumor-Surrogate Blood Vessel Subtypes Exhibit Differential Susceptibility to Anti-VEGF Therapy

(2011) B. Sitohy et al.   CANCER RESEARCH

HCC and angiogenesis: possible targets and future directions

(2011) Andrew X. Zhu et al.   Nature Reviews Clinical Oncology

hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion and side populations

(2010) F Wang et al.   BRITISH JOURNAL OF CANCER

Roles of intrinsic angiogenesis inhibitor, vasohibin, in cervical carcinomas

(2010) Kousuke Yoshinaga et al.   CANCER SCIENCE

TNF/p38α/Polycomb Signaling to Pax7 Locus in Satellite Cells Links Inflammation to the Epigenetic Control of Muscle Regeneration

(2010) Daniela Palacios et al.   Cell Stem Cell

Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretion

(2010) Y. Suzuki et al.   JOURNAL OF CELL SCIENCE

Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis

(2009) Hiroshi Kimura et al.   BLOOD

Vascular Changes in Hepatocellular Carcinoma

(2008) Zhen Fan Yang et al.   Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology

Vasohibin-1 in human breast carcinoma: A potential negative feedback regulator of angiogenesis

(2008) Kentaro Tamaki et al.   CANCER SCIENCE

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE